Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme. (Q50191687)
Jump to navigation
Jump to search
scientific article published on 17 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme. |
scientific article published on 17 April 2013 |
Statements
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme (English)
Anna Maria Di Giacomo
Ester Fonsatti
Erica Bertocci
Isabella Pesce
Carolina Fazio
Ornella Cutaia
Clelia Miracco
Maurizio Biagioli
Maresa Altomonte
17 April 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference